PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15202025-1	2004	Pre-treatment with bryostatin 1 (bryo) has been shown to potentiate the efficacy of (2-chloro-2-deoxyadenosine, cladribine, 2-CdA) in B-cell chronic lymphocytic leukemia (B-CLL) by increasing the ratio of deoxycytidine kinase (dCK) to 5"-nucleotidase (5"-NT) activity.	bryostatin 1	19-31	5'-nucleotidase ecto	Homo sapiens	235-250	
15202025-1	2004	Pre-treatment with bryostatin 1 (bryo) has been shown to potentiate the efficacy of (2-chloro-2-deoxyadenosine, cladribine, 2-CdA) in B-cell chronic lymphocytic leukemia (B-CLL) by increasing the ratio of deoxycytidine kinase (dCK) to 5"-nucleotidase (5"-NT) activity.	bryostatin 1	19-23	5'-nucleotidase ecto	Homo sapiens	235-250